We are live on ! Find out more
BIM

Bogle Investment Management Portfolio holdings

AUM $63M
1-Year Est. Return 51.97%
This Fund
S&P 500
This Quarter Est. Return
+12.38%
1 Year Est. Return
+51.97%
3 Year Est. Return
+181.13%
5 Year Est. Return
+959%
10 Year Est. Return
AUM
$1.44B
AUM Growth
-$54.7M
Cap. Flow
-$92.5M
Cap. Flow %
-6.41%
Top 10 Hldgs %
10.9%
Holding
559
New
183
Increased
65
Reduced
124
Closed
183

Sector Composition

Rank Sector Weight
1 Healthcare 21.18%
2 Industrials 14.86%
3 Technology 14.64%
4 Consumer Discretionary 9.49%
5 Consumer Staples 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOXO
326
DELISTED
Xo Group Inc
XOXO
$463K 0.03%
+26,566
New +$449K
AFSI
327
DELISTED
AmTrust Financial Services, Inc.
AFSI
$460K 0.03%
18,811
-10,389
-36% -$265K
INFI
328
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$459K 0.03%
345,446
-6,343
-2% -$29.7K
GGB icon
329
Gerdau
GGB
$9.74B
$458K 0.03%
317,093
-12,222
-4% -$18K
CIGI icon
330
Colliers International
CIGI
$5.04B
$438K 0.03%
12,857
-26,512
-67% -$1.01M
FRGI
331
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$436K 0.03%
+19,997
New +$564K
AGTC
332
DELISTED
Applied Genetic Technologies Corporation
AGTC
$435K 0.03%
30,797
-73,176
-70% -$1.14M
NTRA icon
333
Natera
NTRA
$38.3B
$432K 0.03%
+35,828
New +$399K
RRTS
334
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$428K 0.03%
+2,299
New +$538K
OEC icon
335
Orion
OEC
$381M
$412K 0.03%
25,951
-43,553
-63% -$654K
AEGR
336
DELISTED
Aegerion Pharmaceuticals
AEGR
$382K 0.03%
256,656
-160,731
-39% -$368K
LAB icon
337
Standard BioTools
LAB
$340M
$367K 0.03%
40,696
-226,227
-85% -$2.13M
TVTX icon
338
Travere Therapeutics
TVTX
$5.2B
$365K 0.03%
+20,543
New +$333K
EPAY
339
DELISTED
Bottomline Technologies Inc
EPAY
$362K 0.03%
+16,841
New +$441K
AVD icon
340
American Vanguard Corp
AVD
$68.4M
$357K 0.02%
23,649
-86,720
-79% -$1.28M
PMC
341
DELISTED
PharMerica Corporation
PMC
$356K 0.02%
+14,449
New +$359K
CHMT
342
DELISTED
Chemtura Corporation
CHMT
$354K 0.02%
13,447
-40,353
-75% -$1.09M
ELOS
343
DELISTED
Syneron Medical Ltd
ELOS
$353K 0.02%
45,992
-7,403
-14% -$52.8K
VECO icon
344
Veeco
VECO
$3.05B
$350K 0.02%
+21,174
New +$377K
INST
345
DELISTED
Instructure, Inc.
INST
$345K 0.02%
+18,209
New +$336K
NOG icon
346
Northern Oil and Gas
NOG
$2.3B
$339K 0.02%
+7,351
New +$345K
CCXI
347
DELISTED
ChemoCentryx, Inc.
CCXI
$338K 0.02%
+75,299
New +$283K
WNC icon
348
Wabash National
WNC
$512M
$335K 0.02%
+26,382
New +$355K
ENIA
349
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$323K 0.02%
+37,677
New +$300K
AIZ icon
350
Assurant
AIZ
$13.8B
$319K 0.02%
3,705
-9,995
-73% -$840K

Similar funds

Bogle Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Bogle Investment Management held 559 positions worth $1.44B, down 3.6% from $1.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bogle Investment Management withdrew a net $92.5M in Q2 2016, closing 183 positions and reducing 124 holdings. Its most notable exit was Hawaiian Holdings, Inc., an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

Against the trend, Bogle Investment Management opened a new position in JOYY Inc worth $13.1M.

  • Bogle Investment Management's largest Q2 2016 buy was JOYY Inc: 387,073 shares worth $13.1M.
  • Bogle Investment Management added most to Trinseo in Q2 2016, an estimated $14.1M increase.
  • Bogle Investment Management's biggest Q2 2016 reduction was AngloGold Ashanti, cutting an estimated $14.2M.
  • Bogle Investment Management fully exited Hawaiian Holdings, Inc. in Q2 2016, selling an estimated $18.1M.
  • Bogle Investment Management's ten largest holdings make up 11% of its $1.44B portfolio in Q2 2016.
  • Bogle Investment Management opened 183 new positions and closed 183 in Q2 2016.
  • Bogle Investment Management's portfolio value fell 3.6% quarter-over-quarter to $1.44B.

Based on Bogle Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.